missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CHRDL1 (aa 250-361) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (88%), Rat (88%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-51362 (PA5-51362. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
CHRDL1 is an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described.
Specifications
Specifications
| Accession Number | Q9BU40 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 91851 |
| Name | Human CHRDL1 (aa 250-361) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | CHL; CHL1; chordin like 1; chordin-like 1; chordin-like protein 1; Chrdl1; dA141H5.1; Kjr; Kohjirin; MGC1; MGCN; neuralin 1; neuralin-1; neurogenesin 1; Neurogenesin-1; Ng1; Nrln1; Ventroptin; ventroptin-alpha; ventroptin-beta; VOPT |
| Common Name | CHRDL1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction